Suscribirse

Implementation of pharmacist targeted discharge prescription review in an emergency department - 09/10/21

Doi : 10.1016/j.ajem.2021.04.054 
Emily Lineberry, PharmD, MS a, 1 , Elizabeth Rozycki, PharmD b , Trisha A. Jordan, PharmD, MS c, d , John Mellett, PharmD, MBA e , Andrew M. North, PharmD, MBA f,
a PGY1/PGY2 MS Health System Pharmacy Administration Resident, Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA 
b Specialty Practice Pharmacist - Emergency Medicine, Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA 
c Director, Patient Care Services, Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA 
d Assistant Professor, College of Pharmacy, The Ohio State University College of Pharmacy, Columbus, OH, USA 
e Clinical Applications Pharmacist, Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA 
f Specialty Practice Pharmacist - Emergency Medicine, Department of Pharmacy, The Ohio State University Wexner Medical Center, 410 West 10th Avenue, 368 Doan Hall, Columbus, OH 43210, USA 

Corresponding author.

Abstract

Background/Purpose

Little data has been published regarding emergency medicine pharmacist (EMP) review of discharge prescriptions. An internal retrospective review of a limited sample size of emergency department (ED) discharge prescriptions demonstrated a 13.6% potential intervention rate by EMPs. With this information, it was postulated that EMPs could provide a valuable service via a process of targeted review of ED discharge prescriptions that would yield intervention rates higher than the internal audit. The aim of this project was therefore to develop a real-time notification system within the electronic health record (EHR) for targeted discharge prescription review, to establish an associated EMP workflow, and to evaluate the intervention rate achieved through targeted discharge prescription review.

Methods

This was a single-center, retrospective review of the implementation of a new pharmacist-driven clinical service over a 12 week period from February 19th, 2018 to May 14th, 2018. Criteria for prescription review were determined after an internal audit by the EMPs and included an assessment of established high-alert medications. Discharge prescriptions that met the inclusion criteria were filtered into a real-time work queue in the EHR for EMP review. When necessary, EMPs discussed recommendations with prescribers, or adjusted prescriptions according to institutional pharmacist privileges. Interventions were reviewed and categorized to assess rate of intervention and the types of medication-related problems (MRPs) identified.

Results

EMPs reviewed 378 discharge prescriptions and a total of 158 prescriptions were identified as having at least one MRP. Of these, 70 prescriptions were intervened upon thereby resulting in an 18.5% intervention rate. The most common interventions included a change in the dose/frequency, duration/refills of the medication, and patient education. The highest number of interventions were made for anticoagulant and antiinfective agents.

Conclusion

Utilization of a real-time notification system for prospective ED discharge prescription review is feasible. Using targeted criteria for review, pharmacists intervened on 18.5% of prescriptions reviewed. Prospective discharge prescription review by EMPs using a real-time notification system within the electronic health record identified opportunities for the pharmacist to ensure safe and optimal prescribing.

El texto completo de este artículo está disponible en PDF.

Highlights

ED discharge prescription review process created for emergency medicine pharmacists.
Impact of targeted prescription review demonstrated by an overall intervention rate of 18.5%.
Anticoagulant & anti-infective prescriptions exhibited highest intervention rates.
Interventions mainly comprised dose/frequency, duration/refills & patient education.
Pharmacist targeted ED discharge prescription review is a feasible clinical service.

El texto completo de este artículo está disponible en PDF.

Keywords : Emergency medicine, Pharmacists, Prescriptions, Patient discharge, Pharmacy service, hospital, Patient safety


Esquema


© 2021  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 48

P. 288-294 - octobre 2021 Regresar al número
Artículo precedente Artículo precedente
  • Evaluation of fixed versus variable dosing of 4-factor prothrombin complex concentrate for emergent warfarin reversal
  • Zachary Stoecker, Brandon Van Amber, Casey Woster, Kurt Isenberger, Marissa Peterson, Paula Rupp, Ella Chrenka, David Dries
| Artículo siguiente Artículo siguiente
  • The effect of point-of-care ultrasound on length of stay in the emergency department in children with neck swelling
  • Mary Kate Claiborne, Carrie Ng, Kristen A. Breslin, James Chamberlain, Rosemary Thomas-Mohtat

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.